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Abstract
HIV-1 virions infect target cells by first establishing contact between envelope glycoprotein trimers on the virion’s surface
and CD4 receptors on a target cell, recruiting co-receptors, fusing with the cell membrane and finally releasing the genetic
material into the target cell. Specific experimental setups allow the study of the number of trimer-receptor-interactions
needed for infection, i.e., the stoichiometry of entry and also the number of antibodies needed to prevent one trimer from
engaging successfully in the entry process, i.e., the stoichiometry of (trimer) neutralization. Mathematical models are required
to infer the stoichiometric parameters from these experimental data. Recently, we developed mathematical models for the
estimations of the stoichiometry of entry [1]. In this article, we show how our models can be extended to investigate the
stoichiometry of trimer neutralization. We study how various biological parameters affect the estimate of the stoichiometry
of neutralization. We find that the distribution of trimer numbers—which is also an important determinant of the
stoichiometry of entry—influences the estimated value of the stoichiometry of neutralization. In contrast, other parameters,
which characterize the experimental system, diminish the information we can extract from the data about the stoichiometry
of neutralization, and thus reduce our confidence in the estimate. We illustrate the use of our models by re-analyzing
previously published data on the neutralization sensitivity [2], which contains measurements of neutralization sensitivity of
viruses with different envelope proteins to antibodies with various specificities. Our mathematical framework represents the
formal basis for the estimation of the stoichiometry of neutralization. Together with the stoichiometry of entry, the
stoichiometry of trimer neutralization will allow one to calculate how many antibodies are required to neutralize a virion or
even an entire population of virions.
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Introduction
Virions of human immunodeficiency virus (HIV) are coated by
a lipid bilayer. Trimers of the dimeric envelope proteins (Envs)
gp120 and gp41 are inserted into this membrane [3–5]. These
trimers, often also referred to with the more general term spikes,
can bind to CD4 receptors [6,7]. After successful engagement of
CD4, the envelope trimer undergoes conformational changes that
allow a coreceptor, most commonly chemokine receptors CCR5
and CXCR4, to bind [8]. Binding to the coreceptor initiates a
series of rearrangements in the viral envelope protein gp41, which
upon insertion of the fusion peptide into the cellular membrane
brings together viral and cellular membrane and triggers the fusion
process. Possible targets for neutralizing antibodies have been
identified over the past decades and are restricted to accessible
conserved regions on the Env trimers [9,10].
Estimating the number of monoclonal antibodies or inhibitory
molecules needed to block a single trimer together with estimates
of other parameters that characterize the molecular interaction of
the virus with its target cells and antibodies, may eventually allow
us to predict the antibody concentrations required to inhibit viral
replication in vitro and within the infected individual. This
quantitative understanding of neutralizing antibody activity will
aid the development of antibody vaccines and entry inhibitors.
In this paper, we develop a mathematical framework to estimate
how many antibodies are needed to neutralize a single trimer. This
number is referred to as stoichiometry of trimer neutralization or short
stoichiometry of neutralization. The mathematical models, which we
introduce here, are based on the models we developed for the
analysis of the number of trimers required for cell entry [1]. As for
the stoichiometry of entry, we investigate models differing with
respect to the biological assumptions about the exact molecular
mechanisms involved in the generation of pseudotyped virions. To
illustrate how to use our model to estimate the stoichiometry of
neutralization, we reanalyze previously published data by [2].
Models
Experimental setup for the determination of the
stoichiometry of neutralization
Here, we briefly introduce the experimental setup for the
determination of the stoichiometry of neutralization, in particular
those aspects relevant for the development of the mathematical
models in the next section. The experimental setup is described in
more detail in [1,2,11].
Envelope-pseudotyped HIV virions are generated by transfec-
tion of virus producer cells (293T) with a set of plasmids. One
plasmid provides all the genetic information to assemble infectious
virions with the exception of the viral envelope. The genetic
information for viral envelope proteins is provided on separate
plasmids. A third plasmid encodes for the firefly luciferase reporter
gene under the control of HIV LTR, which allows rapid detection
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proteins and are infectious but are only capable of completing one
infection cycle, as the genetic information packaged into the
virions lacks essential genes.
To study the stoichiometry of neutralization pseudotyped
virions with mixed envelope proteins are generated. Hereby,
plasmids encoding for wild-type envelope proteins are transfected
along with plasmids encoding for neutralization-resistant envelope
proteins. As a result, the plasmid pool in the producer cell consists
of a mixture of wild-type and mutant envelope proteins. Proteins
from this pool trimerize and, as a consequence, a fraction of the
envelope trimers are wild-type/mutant hetero-trimers. We denote
the fraction of mutant envelope protein encoding plasmids by fR.
The mutant envelopes harbor only one (or few) amino acid
changes compared to the wild-type that render them resistant to a
specific neutralizing antibody. Otherwise the mutant envelope
proteins are fully functional and can form functional hetero-
trimers [12].
The infectivity of these pseudotyped virions with mixed
envelope protein trimers is then measured. Before these virions
infect target cells, they are saturated with monoclonal antibodies
that bind to all wild-type envelope proteins. As a consequence,
only mutant envelope proteins can take part in attachment to
CD4-receptors. In this assay, infectivity is measured via the
luciferase reporter gene, which is expressed upon infection of
susceptible target cells. The luciferase activity (measured as
emitted relative light units) in the infected cell population is
proportional to the number of virions that successfully entered and
integrated into a cell. The infectivity is normalized to a virus stock
that contains 100% wild-type Envs. Similar to the study of the
stoichiometry of entry [1], the relative infectivity, RI, is
determined for different fractions fR of mutated envelope encoding
plasmids.
Mathematical models for trimer neutralization
The mathematical models to infer the stoichiometry of (trimer)
neutralization, N, incorporate the combinatorial aspects of the
assembly of pseudotyped virions with mixed envelope proteins and
the infection of cells in the infectivity assay.
One of the most important input parameter in all of these
models is the distribution of the number of trimers on the surface
of virions. We include this distribution in a generic form with the
parameters gs [½0,1 , s~0,...,smax, where gs denotes the fraction
of virions with s trimers. Note that this distribution only describes
the numerical and not the spatial distribution of trimers on the
virion’s surface.
For the basic model we assume that the envelope proteins to be
assembled into trimers are sampled out of an envelope pool. The
fraction of mutated envelope proteins in this pool is equal to the
fraction of mutant Env encoding plasmids in the transfection
medium, fR. Trimers are formed perfectly randomly from the
envelope proteins in the pool, i.e. the number of mutated Env
proteins is binomial distributed. Virions can infect a cell if they
have at least T functional trimers.
In the four model extensions we relax different assumptions of
the basic model.
N In the imperfect transfection model we allow the fraction of mutant
envelope proteins in the envelope pool to differ from the
fraction of mutant Env-encoding plasmids.
N For the segregation model we relax the assumption of binomial-
distributed trimer assembly, i.e. the formation of trimers with
only wild-type or mutant envelope proteins becomes more
likely.
N In the proximity model, we assume that trimers have to be
sufficiently close to each other to engage with the CD4
receptor on the target cell.
N In the soft threshold models we relax the assumption of a strict
thresholds. Since our models involve two threshold parame-
ters, the stoichiometry of entry and the stoichiometry of
neutralization, we can formulate two types of soft threshold
models.
Which virions end up infecting a cell? To answer this question
we first have to zoom in on the trimeric level. A trimer is called
functional if it is able to take part in mediating cell entry. As virions
are saturated with antibodies before the infection experiments,
this ability is dependent on the stoichiometry parameter N.I n
the absence of antibodies, both mutant and wild-type Envs are
assumed to be perfectly functional and give rise to infectious
particles. In the investigated setup however, antibodies bind to
wild-type Envs and all wild-type Envs are assumed to be bound
by one antibody. If a trimer has N or more wild-type envelope
proteins, this trimer is neutralized. Hence, in this setup only
trimers with more than (3{N) mutated envelope proteins are
functional trimers. Figure 1 gives an overview of functional and
non-functional trimers depending on the stoichiometry of
neutralization N. Here lies the important difference between
the scenario studied in our work on HIV-entry [1] and the assays
to estimate the neutralization parameter [2]. For estimating the
entry parameter a mutation was used which renders the complete
trimer binding-incapable, i.e. only trimers without any mutated
Env protein are functional ones. In the neutralization assay, both
wild-type and mutant Envs are infectious and only wild-type
Envs can be rendered non-infectious by binding neutralizing
antibody.
Not all virions that can potentially infect a cell end up in
successfully infecting a cell. We call a virion infectious if it has the
potential to infect a cell. Therefore it has to fulfill special
conditions concerning the number of functional trimers which
depend on the model and which are defined for every model
separately. We assume that every infectious virion has the same
probability to infect a cell independent of the number of functional
trimers. Since we study the infectivities of a mixed virion stock in
comparison to a wild-type stock this quantity cancels out in the
calculations.
Author Summary
A large part of the research on the Human Immunodefi-
ciency Virus focuses on how virus particles attach and
enter their target cells, and how entry can be inhibited by
antibodies or antiretroviral drugs. Because virus particles
are too small to be observed in action the inference of the
details of HIV entry has to be indirect—involving the
genetic manipulation of virions, and often mathematical
modeling. It is known that virus particles establish contact
to their target cells with spikes on their surface, and
antibodies binding to these spikes can inhibit virus entry. It
is not known, however, how many antibodies are needed
to neutralize a spike. In this article, we develop a
mathematical framework to estimate this number, called
the stoichiometry of neutralization, from data obtained in
experiments with genetically engineered virions. An
estimate of the stoichiometry of neutralization for different
antibodies is important, as it will allow us to calculate
the amount of antibodies required to abrogate virus
replication.
Stoichiometry of HIV Neutralization
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stoichiometry parameter of entry as described in [1], i.e. the
number of trimers needed for attachment to target cell receptors,
fusion and release of the virus’ genetic material into the target cell.
Let N be the stoichiometry parameter of neutralization, i.e. the
minimal number of antibodies needed to render a trimer non-
functional. Since monoclonal antibodies are used, each antibody
can only bind to a specific region of the envelope protein and N
equals either 1,2 or 3.
Let us assume that each envelope protein has the same chance
to be selected out of the envelope pool during trimer assembly.
Only trimers with more than (3{N) mutated envelope proteins
are functional (in this case, the trimer has less than N wild-type
Envs). Hence, the probability that a trimer is functional, aN, is:
aN~
X 3
m~(3{N)z1
3
m
  
f m
R (1{fR)
3{m ð1Þ
Each trimer is assembled independently and for a virion with s
trimers on its surface, the probability that it has g functional
trimers is:
s
g
  
a
g
N 1{aN ðÞ
s{g ð2Þ
In the basic model the condition for an infectious virion is the
following: A virion is infectious if there are at least T functional
trimers (trimers with more than (3{N) mutated envelope
proteins) on its surface. The probability that a virion with exactly
s trimers is infectious is equivalent to the probability that it has at
least T functional trimers. This can be calculated as:
X s
g~T
s
g
  
a
g
N 1{aN ðÞ
s{g ð3Þ
The relative infectivity obtained by experiments is a comparison of
the emitted light of an infectivity assay with a pseudotyped virus
stock and the emitted light of an infectivity assay with a wild-type
virus stock. Hence, the relative infectivity is a function of the
fraction fR of mutated Env encoding plasmids. Wild-type virions
have only functional trimers, and therefore all virions with more
than T trimers are infectious. Since the probability that a virion
has s trimers is gs, the fraction of infectious wild-type virions is Psmax
s~T gs. The probability that a virion with s trimers is infectious
in equation 1 has to be weighted by the probability gs that a virion
has s trimers and we obtain the following analytical expression for
the relative infectivity:
RIN, basic~
P smax
s~T
gs
P s
g~T
s
g
  
a
g
N 1{aN ðÞ
s{g
 !
P smax
s~T
gs
ð4Þ
Using equation 4, we can infer the stoichiometry parameter of
neutralization N from the observed relative infectivity for various
values of fR, knowing the distribution of trimer numbers gs and the
stoichiometry of entry. It is also possible to estimate the two
stoichiometry parameters N and T simultaneously.
Yang et al. studied the neutralization sensitivity %NS [2]. This
is the percentage of virions that can be neutralized or in other
words the percentage of virions which can not infect. Hence, the
relative infectivity is
RI~1{%NS ð5Þ
Imperfect transfection. As in the basic model, a virion is
infectious if it has at least T functional trimers. Each trimer has to
have more than 3{N mutated envelope proteins to be functional.
In contrast to the basic model, we do not equal the fraction of
mutated Env encoding plasmids with the fraction of mutated
envelope proteins in the Env pool. Two mechanisms can result in
a difference between these two fractions: a) only small or variable
numbers of plasmids could enter the transfectable cell or b)
different quality of plasmid preparation can lead to differential
expression of the Env proteins.
The variation of the fraction of envelope proteins in the Env
pool is modeled as a B-distributed random variable with mean fR.
As in the entry model (cf. [1]), the variance v of this distribution is
defined as
v :~~ v vfR(1{fR) ð6Þ
with a parameter 0v~ v vv1, called variance coefficient. We still assume
binomial trimer assembly. Since the fraction of mutant envelope
protein is now B{distributed, the probability that a functional
trimer is formed in the imperfect transfection model is an integral.
The integrand is the same as equation 1, weighted with the
probability density function of the B-distribution with mean fR and
Figure 1. Dependence of the stoichiometry of neutralization, N, on the trimer’s infectiousness. Wild-type envelope proteins are colored
black, mutant envelope proteins red and antibodies green. Due to saturation with antibodies prior to the infectivity experiments, all wild-type
envelope proteins are assumed to be bound. Functional trimers are marked with ‘‘+’’, non-functional ones with ‘‘2’’.
doi:10.1371/journal.pcbi.1000713.g001
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aitm
N ~
X 3
m~(3{N)z1
ð1
0
3
m
  
xm(1{x)
3{mbfR,v(x)dx ð7Þ
The relative infectivity can now be computed by replacing the
probability of forming a functional trimer in the basic model, aN,
with the probability to form a functional trimer in the imperfect
model, aitm
N :
RIN, itm~
P smax
s~T
gs
P s
g~T
s
g
  
aitm
N
   g 1{aitm
N
   s{g
 !
P smax
s~T
gs
ð8Þ
This model can be fitted to the data of Yang et al. [2], by either
using the estimated parameters for T and ~ v v or by estimating N, T
and ~ v v simultaneously.
A model allowing for segregation of envelope proteins
within transfected cells. As in the basic and the imperfect
transfection model, a virion is infectious if it has at least T
functional trimers on its surface. A trimer is functional, if there are
more than (3{N) mutated envelope proteins.
In the basicmodel, theformationof trimersisassumedto followa
binomialdistribution.Thismeansthattoformatrimertheenvelope
proteins are sampled from the envelope pool within the cell and the
probability to chose one trimer is equally likely for every trimer in
this pool. There is evidence that, when two different HIV-1
glycoproteins are expressed in the same cell, hetero-trimers are
formed and recruited to the surface of virions [13,14]. This
phenomenon was even observed for coexpressed HIV-1 and HIV-2
envelope proteins [12] and for mixed HA-trimers in influenza A
strains [15]. Despite empirical evidence for the existence of hetero-
trimers, it is to date unclear if their frequency is consistent with a
process of trimer formation that follows a binomial distribution (i.e.,
loosely speaking, is ‘‘perfectly random’’). Therefore, in the
segregation model, we assume the process of trimer formation to
be skewed towards the formation of homo-trimers.
We include the segregation parameter j, 0ƒjƒ1. j~0 correspond
to no segregation (and this is equivalent to the basic model) and
j~1 stands for full segregation, i.e. no hetero-trimers are formed.
The probability to draw a mutated envelope protein out of the
Env pool is fR, the probability to get a wild-type protein in the first
draw is (1{fR). The probability that the second Env is a mutant
given the first Env is a mutant is assumed to be f
1{j
R . Since fR is
less than 1, f
1{j
R is greater than fR (except for j~0, in this case it
is equal). The probability that the second Env is a wild-type given
the first one is a mutant Env is (1{f
1{j
R ). These probabilities are
also valid for the third envelope protein. Similar to this definition,
the probabilities that the second (third) envelope protein is a wild-
type given the first one is a wild-type envelope equals (1{fR)
1{j,
respectively the probability that the second (third) Env is a mutant
given the first one is a wild-type is then 1{(1{fR)
1{j   
. Now we
can derive the probabilities that a trimer has 1,2 or 3 mutant
envelope proteins, called P1,P2 respectively P3:
P3~f
3{2j
R
P2~(1{fR)1 {(1{fR)
1{j    2
z2f
2{j
R 1{f
1{j
R
  
P1~fR 1{f
1{j
R
   2
z2(1{fR)
2{j 1{(1{fR)
1{j   
ð9Þ
If N equals 1, only trimers with 3 mutant Envs are infectious. If
N~2, trimers with 2 or 3 mutant Envs and if N~3, trimers with
1, 2 or 3 mutant Envs are infectious. The probability that a trimer
is infectious is therefore
a
seg
N :~1f1,2,3g(N)P3z1f2,3g(N)P2z1f3g(N)P1 ð10Þ
with Pi defined in equation 9 and 1A(x)~1 for x[A and 1A(x)~0
else.
Let gs, s~0,...,smax be the probability that a virion has s
trimers. Hence, the relative infectivity is:
RIN, seg~
P smax
s~T
gs
P s
g~T
s
g
  
a
seg
N
   g 1{a
seg
N
   s{g
 !
P smax
s~T
gs
ð11Þ
For fitting this model to the data of Yang et al. [2] one can
either use the parameters we estimated in [1] for T and j or
estimate them beside the stoichiometry of neutralization.
Correcting for proximity requirements. In the proximity
corrected model, the definition of a functional trimer given in the
basic model is valid once again, i.e. there have to be more than
(3{N) mutated Env proteins in the trimer. This happens with the
probability aN described in equation 1, i.e. we drop the
segregation assumption.
In the basic model, a virion is infectious if there are at least T
functional trimers independent of the trimers’ location on the
virion’s surface. This assumption is reasonable if trimers can move
freely on the cell surface or if trimers are recruited to the site of
contact between the virion and the target cell. Some studies using
cryoelectron microscopy tomography suggest indirectly that
trimers can indeed move freely [16,17]. On the other hand, Zhu
et al. [18] conclude from their study, that trimers seem to have
fixed positions on the surface. To model a scenario with fixed
trimer positions, we assume, that there has to be a group of at least
T trimers that are sufficiently close together. This group of trimers
then establishes the contact between the virion and the target cell.
The critical distance, i.e. the maximal distance between each pair
of trimers within this group, is denoted with a.
Deriving an analyzable mathematical expression for the relative
infectivity is impossible, so we simulate nv virtual virions with
randomly distributed trimer numbers where the probability that a
virion has s trimers equals gs. The probability to form a functional
trimer is aN, defined in equation 1. The number of functional
trimers on a virion with s trimers is therefore binomial distributed
with the parameters s and aN (*B(s,aN)). The functional trimers
are now distributed randomly on the surface of a spherical virion.
If there are at least T functional trimers with a pairwise distance
less than the distance parameter a, the virion is counted as an
infectious one. To obtain the relative infectivity for a certain
fraction fR of mutated Env encoding plasmids, we simulate the
number of infectious virions with the value of fR and compare that
to the number of infectious virions simulated with nv not
neutralized wild-type virions. For a more detailed description of
the simulation procedure confer the explanation of the simulation
in the proximity corrected model for HIV-entry in [1].
Soft threshold models. In the previous models we have
assumed, that a virion is either infectious or not. Virions with at
least T functional trimers are infectious in the basic and
segregation model, and in the proximity corrected model these
Stoichiometry of HIV Neutralization
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However, one can imagine that all virions are able to infect target
cells but not with the same probability, e.g., a virion with 10
functional trimers infects a target cell with two times the
probability that a virion with 5 functional trimers end up
infecting a cell.
To integrate this idea into our model, we assume that the
probability of infectiousness follows a Hill-function. This means
that the probability that a virion with g functional trimers is
infectious equals
c(g)~
gh
ghzTh
1=2
ð12Þ
This definition allows the analysis of a very broad spectrum of
infectiousness models. The parameter T1=2 is the number of
functional trimers for which the infectiousness probability is 0.5.
We assume this parameter to be continuous and bounded by 100,
because the maximal number of trimers on a virion is assumed to
be 100. The parameter h determines the steepness of the
infectiousness curve (cf. [1]).
There are two possibilities to define a functional trimer. The
first is the definition we used in the basic and proximity corrected
model, namely that a trimer is functional, when it has less than N
wild-type envelope proteins (i.e. more than (3{N) mutant Env).
The model is described in equation 13. The second model includes
a soft threshold on the trimeric level and is described by equations
14 and 15.
As in the previous models the number of trimers on the virion’s
surface is distributed according to gs, s~0,...,smax.
(i) A soft threshold for entry: A trimer is functional, if there are
more than (3{N) mutant envelope proteins. A trimer with g
functional spikes is infectious with the probability c(g),
defined in equation 12. Since all virions with at least 1 trimer
can be infectious, for the relative infectivity one has to sum
over all possible trimer numbers and the possible numbers of
functional trimers. Therefore, the relative infectivity is:
RIN, ste~
P smax
s~1
gs
P s
g~1
c(g)
s
g
  
a
g
N(1{aN)
s{g
 !
P smax
s~1
gsc(s)
ð13Þ
(ii) A soft threshold for entry and neutralization: Here we relax
the assumption that a trimer needs a certain number of
antibodies to be neutralized. It is now assumed that the
functionality of a trimer, that is the ability to bind to a target
cell receptor, is only reduced by antibody-binding. A trimer
to which no antibody is bound has a functionality of 1, and a
trimer bounded by 3 antibodies is completely neutralized,
i.e. its functionality is 0. The functionality of trimers with
one respectively two antibodies are p1 resp. p2,w i t hp1§p2.
This concept is illustrated in figure 2. Antibodies can only
bind to wild-type envelope proteins. This means that the
number of antibodies bound to a trimer equals the number
of wild-type Envs. The mean functionality can now be
calculated by weighting the functionality parameters by the
probability of having 0,1,2 resp. 3 wild-type envelope
proteins. Hence, the mean functionality G is:
G~1:f 3
Rzp1:3f 2
R(1{fR)zp2:3fR(1{fR)
2 ð14Þ
The expected functionality of one trimer has to be multiplied by
the number s of trimers on a virion to obtain the expected
functionality of a virion with s trimers. The infectiousness can now
be calculated with equation 12 and 14 as:
RIN, sten~
P smax
s~1
gsc(sG)
P smax
s~1
gsc(s)
ð15Þ
Equations 13 and 15 are used to fit the soft threshold models to
the data of Yang et al. [2]. For the soft threshold model for entry,
we can use the parameters obtained in [1], but we also can
estimate h, T1=2 and N simultaneously. The soft threshold model
for entry and neutralization is only fitted under the assumptions,
that the parameters for h and T1=2 estimated in [1] hold true, i.e.
only p1, p2 and N are estimated.
The definitions of all model parameters are summarized in
table 1. The expressions in equations 4, 8, 11, 13 and 15 were
implemented as functions in the R language for statistical
computing [19]. The proximity corrected model is only simulated,
due to the lack of an analytical expression for this model. To
reduce runtime, the algorithm was implemented in C and loaded
into R as a shared library. The programs can be obtained upon
request.
Results
Effect of the stoichiometry of neutralization N and the
distribution of trimer numbers g on the relative infectivity
In this section, we first analyze the effects of the input
parameters on the predicted relative infectivity. We show
predictions for the basic model in detail. Reversing these
Figure 2. Functionality, i.e. probability of a trimer neutralized
by some antibodies to take part in attachment to virus.
doi:10.1371/journal.pcbi.1000713.g002
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below by fitting our mathematical models to data obtained by
experiments of Yang et al. [2].
The relative infectivity RI increases with the fraction of
neutralization resistant envelope proteins fR. This is quite intuitive
because, the more neutralization resistant envelope proteins exist
in the transfectable cell, the more trimers with a high number of
mutant envelopes are assembled. These trimers are more likely to
be functional in the presence of antibody.
The higher the stoichiometry of neutralization N, the more the
relative infectivity curve is shifted to the left (see figure 3 (A)). For
example, let us assume only virions with exactly 10 trimers of
which 8 trimers are needed for entry (T~8). If three antibodies
are needed to neutralize one trimer (N~3) a trimer with one or
more mutant envelope proteins is functional. For a fraction of
neutralization resistant envelope proteins fR~0:4, the probability
for a functional trimer is 78.4% and this leads to a relative
infectivity RI~0:63 (see figure 3 (A)). In contrast, the relative
infectivity for N~2 and N~1 are almost 0 due to the small
probabilities for functional trimers. Only 35.2% of all trimers are
functional if 2 antibodies are needed for neutralization (N~2),
and 6.4% are functional for N~1.
The stoichiometry of entry T describes the minimal number of
trimer-target cell receptor interactions needed to mediate cell
entry. If only few trimers are necessary for attachment and entry,
the probability that a virion has enough functional trimers is much
higher than for a large number of trimer–target interactions T.
Therefore the predicted relative infectivity decreases with the
stoichiometry of entry T (cf. the blue and black solid curves in
figure 3 (B)).
A problem for the estimation of the stoichiometric parameters is
that there are various combinations of T and N which give rise to
very similar predicted relative infectivities. As an example, let us
assume a virion population with exactly 10 trimers per virion. For
this situation the stoichiometry parameter pairs N~1, T~3;
N~2, T~7 and N~3, T~10 predict similar relative infectivity
values (see the blue curves in figure 3 (B)). This suggests that it is
not advisable to estimate both stoichiometry parameters N and T
simultaneously (see also below).
As shown in figure 3 (C) mean and variance of the distribution
of trimer numbers g play also important roles for the predictions of
the relative infectivity. The higher the mean trimer number, the
faster the relative infectivity increases. The variance of the trimer
number distribution changes the smoothness of the predicted
relative infectivity curve. Since parameter estimations are based on
the predicted relative infectivites, it is necessary to include as much
information as possible about the distribution of trimer numbers.
[18] investigated trimers on HIV-1 virions and found trimer
numbers of 14+7 trimers on a virion’s surface. Since we do not
have more detailed information about trimer number distribution,
our estimates are based on a discretized B-distribution with mean
14 and standard deviation 7 (see figure 5 in [1]).
Effects of the variance and segregation coefficient
Essential for the estimation of the stoichiometric parameters
is the presence of hetero-trimers. As one can see in figure 1 wild-
type homo-trimers are neutralized for every stoichiometry of
neutralization N and mutant homo-trimers are not neutralized for
any N. Therefore, most of the information about the stoichiom-
etry of neutralization is contained in the infectivity of virions with
hetero-trimers.
In the imperfect transfection model, we introduce the variance
coefficient ~ v v to allow the envelope pool to vary from the fraction of
antibody-resistant Env-mutant encoding plasmids fR. A high ~ v v
corresponds to a scenario in which almost all cells are transfected
exclusively with either wild-type or mutant Env encoding
plasmids. As the presence of hetero-trimers is crucial for the
determination of the stoichiometry of neutralization, the distin-
guishability between different estimates of the stoichiometry of
neutralization decreases with increasing ~ v v. This effect is depicted in
figure 4 (A) and (B). From this figure it becomes clear that for
variance coefficients ~ v v close to one different values of the
stoichiometry of neutralization lead to almost identical predictions
of the relative infectivity and make a reliable estimate for the
stoichiometry of neutralization impossible.
In the segregation model, the segregation coefficient j allows a
deviance from the binomial sampling from envelope proteins out
of the envelope pool. When j is very close to 1, almost only homo-
trimers are formed. Therefore the distinguishability between the
predictions of the relative infectivity for the different stoichiom-
etries of neutralization N decreases with increasing j (see figure 4
(C) and (D)). As for high values of ~ v v, the estimation of the
stoichiometry of neutralization is extremely difficult when the
segregation parameter is close to 1.
An example of parameter estimation
To estimate the stoichiometry of neutralization and the other
model parameters, we re-analyze data obtained in [2]. Yang et al.
investigated 4 different HIV1-strains (ADA, YU2, HXBc2 and
KB9) which in sum had 11 different envelope glycoprotein
mutants that rendered them insensitive to one or several of the 9
different neutralizing antibodies (b12, 2F5, 2G12, 1121 F105,
F91,15e,17b and 48d). Infectivity and neutralization was studied
on two different target cell types (Cf2Th-CD4/CCR5 and Cf2Th-
CD4/CXCR4). In total, 15 different virus antibody combinations
were available for our reanalysis [2]. To demonstrate how our
models can be used to derive the stoichiometry of neutralization,
we treat this data set in two different ways. First, we include all
data points into our estimation. This assumes that all antibodies
have the same stoichiometry. However, it could be possible, that
the stoichiometry of trimer neutralization varies between different
Table 1. Parameter definitions.
s number of trimers on virion
gs probability that virion has s trimers
fM fraction of dominant negative Env-mutant encoding plasmids
fR fraction of antibody-resistant Env-mutant encoding plasmids
p3 probability of forming a ‘‘functional’’ trimer in the entry assay,
(1{fM)
3
aN probability of forming a ‘‘functional’’ spike in the neutralization
assay, see equation (1)
g number of ‘‘functional’’ trimer on virion
T number of trimer-receptor interactions needed for entry
N number of antibodies-Env interactions required to neutralize
one spike
~ v v variance coefficient (imperfect transfection model)
j segregation coefficient ranging from 0 (no segregation) to 1
(full segregation)
a maximal distance of trimers required for cooperation in an
infective cluster
T1=2 Number of trimers for which infectivity is 1/2
h softness parameter (Hill coeficient) in the soft threshold model
doi:10.1371/journal.pcbi.1000713.t001
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sufficient for trimer neutralization whereas for another sort of
antibodies two or three abs could be needed to neutralize one
trimer. For this analysis, a statistically sufficient number of
experiments for the same combination of viral strain, envelopes
mutation, antibody and target cell would be required. Since the
data set [2] is not sufficient to analyze single antibody-virus
combinations, we divide these combinations into 5 groups
according to the antibody binding sites. Antibodies F105, b12,
15e and F91 interfere with the CD4 binding site [20–23] and are
classified as CD4BS-group. Antibodies 17b and 48d bind to a highly
conserved region induced upon CD4 engagement which is
important for gp120-chemokine receptor interaction [24,25] and
belong to the CD4i-group. The other three monoclonal antibodies
have different binding sites and could not be grouped together.
These are 2F5 that binds a linear gp41 epitope proximal to the
viral membrane [26], 2G12 that recognizes a carbohydrate-
dependent epitope on the gp120 surface [27] and antibody 1121
that recognizes the gp120 V3 loop (ImmunoDiagnostics, Inc.).
We first assume that model parameters for entry derived in [1]
are valid for the neutralization assays data from Yang et al. [2].
Under this assumption, we analyze the data either pooling over all
antibody-virus combinations, or stratifying with respect to
antibody binding site (grouped data). Then we also estimate the
parameter of neutralization along with the parameters of entry for
the different models, and compare these estimates with the
estimates for the neutralization parameter alone.
Estimation of the stoichiometry of neutralization. First,
we estimate an average stoichiometry parameter N by pooling all
data over different antibody-virus combinations. Thus, in our
models, we assume that the number of antibodies, which
neutralize one trimer, is the same for all antibodies.
Assuming that the stoichiometry parameter of entry T equals 8,
we estimate N~1 for the basic model (see figure 5) with more
than 99.9% confidence, determined in a bootstrap procedure with
1000 replicates.
In [1], the estimated parameters for the imperfect transfec-
tion model are T~19 and ~ v v~0:99992. Including these values in
fitting the imperfect transfection model to Yang’s neutralization
data, we obtain the best fit with N~3. This model extension
describes the data significantly better than the basic model
(p~2:7|10{7). However, the estimation is not very reliable. In
Figure 3. The relative infectivity in the basic model predicted by equation 4 as a function of the fraction f R of neutralization
resistant envelope proteins. For plot (A) and (B) we assume that each virion has exactly 10 trimers. For plot (A) and (C) the stoichiometry
parameter of entry T equals 8, according to our estimates in [1]. (A) Dependence of the relative infectivity on the stoichiometry parameter N. (B)
Dependence of the relative infectivity on the stoichiometry of entry T. (C) Dependence of the relative infectivity on the mean and variance of trimer
numbers. For this plot the stoichiometry parameter N is set to 1. Solid lines are based on a mean number of trimers equal to 10. Dashed lines have a
mean trimer number of 36. For the black curves the number of trimers is exactly 10 respectively 36 and the distribution of trimer numbers for the red
curves are discrete uniform distributions with 2 to 18 respectively 0 to 72 trimers.
doi:10.1371/journal.pcbi.1000713.g003
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are N~3, whereas 33:1% are N~1 and 0.2% are N~2. The
reason for the high uncertainty in the estimate is the high variance
coefficient ~ v v~0:99992 (see also the explanations in the subsection
‘‘Effects of the variance and segregation coefficient’’).
There are similar problems with the estimation of the
stoichiometry of neutralization N in the segregation model.
The parameters estimated for entry in [1] are T~19 and
j~0:999934. This value is very close to 1 and therefore the
estimation of N is not reliable. This is also reflected in the
uncertainty ofthe estimates:Althoughthebest estimateis N~2 and
explains a higherfractionof the variability in the neutralization data
by Yang et al. [2] (F-test, p~2:75|10{7), a bootstrap procedure
results in N~1 in 21.3%, N~2 in 41.5%, and N~3 in 37.2% of
all replicates (see also the explanations in the subsection ‘‘Effects of
the variance and segregation coefficient’’).
For the entry and the distance parameter in the proximity
model, the best fit is obtained for T~2 and a~10nm (if we
assume the diameter of HIV-1 virions to be 100nm). The
stoichiometry of neutralization, for which the predictions for the
relative infectivity fits the data the best, is N~1 (see figure 5) with
100% confidence (bootstrap procedure). The proximity model fits
the data significantly better than the basic model (p~4:1|10{5).
The soft threshold model for entry has two parameters
which are important for the predictions of the relative infectivity in
the entry process: h~1:26 and T1=2~100. Assuming these
parameters, the stoichiometry parameter for neutralization is
N~1 (see figure 5) and a bootstrap routine gives w99:9%
confidence in this estimate. This model extension is significantly
better than the basic model (p~9:3|10{11). When fitting the
soft threshold model for entry and neutralization to the
data, the functionality parameters p1,p2 for one respectively two
antibodies are both p1~p2~0:055. This means that the trimer’s
ability to mediate cell entry almost vanishes when one antibody
binds to the trimer. The improvement of the predictions for the
relative infectivity by including a soft threshold for the function-
ality of trimers is not significant (p=0.08). We therefore disregard
this model from now on.
Figure 4. Loss of distinguishability of estimates of the stoichiometry of neutralization N in the imperfect transfection model and
the segregation model. (A) Dependence of the predicted relative infectivity in the imperfect transfection model on the stoichiometry parameter
N, the entry parameters for this figure are T~19 and ~ v v~0:5. (B) The area between predictions for N~1 and N~3 is depicted in dependence of the
variance coefficient ~ v v. The decrease of this area size with increasing ~ v v makes the differentiation between different stoichiometries of neutralization
difficult for high values of ~ v v. (C) and (D) show the same phenomenon for the segregation model. The parameters for (C) are T~19 and j~0:5. The
stoichiometry of entry for (B) and (D) is T~19.
doi:10.1371/journal.pcbi.1000713.g004
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stoichiometries of neutralization. To this end, we stratified the data
set with regard to 5 groups corresponding to different binding sites.
This model extension did not fit the data significantly better than
the model assuming N to be equal across binding groups.
Furthermore, all estimates for N were 1 in the models that allow
for reliable estimation (the basic, proximity, and soft threshold
models).
Simultaneous estimation of the stoichiometry of entry
and neutralization. It is also possible to estimate the
stoichiometry of neutralization and entry simultaneously,
rather than estimating only the stoichiometry of neutralization
using independently estimated stoichiometric parameters of
entry as in the previous subsection. Adopting this approach,
one obtains N~1 and T~9 fitting the basic model to Yang’s
data [2]. A bootstrap routine with 1,000 replicates yielded N~1
in 100% of the cases, whereas the estimate for the stoichiometry
of entry was T~9 in 80%, and T~8 in 20% of the bootstrap
replicates. Stratifying the data with respect to different antibody-
binding sites, we obtain the same parameter estimates with
larger confidence intervals. In particular, for antibodies binding
t ot h eC D 4b i n d i n gs i t ea n dt h ea n t i b o d y2 G 1 2t h e
stoichiometry of neutralization is estimated to be N~1 with
99.8% and 97% probability, respectively. For the other antibody
classes, N~2 cannot be excluded at a significance level of
a~0:05.
The approach of simultaneously estimating the stoichiometry of
neutralization and entry does not yield estimates with sufficient
confidence for the imperfect transfection and the segregation
models. Estimates with the proximity corrected model cannot be
obtained due to computational constraints. The soft threshold
model for entry yields parameter estimates very similar to those
obtained by independent estimation of neutralization and entry
parameters. Stratifying data by antibody binding site does not
change this result significantly.
Discussion
In this paper, we developed a framework for the estimation of
the stoichiometry of HIV neutralization and, as an example how
to apply these models, we reanalyze neutralization data [2]. As in
our framework for the estimation of the stoichiometry of entry [1],
we find that the distribution of trimer numbers is essential for the
estimation of the stoichiometry of neutralization. A second major
finding is, that the stoichiometry of neutralization may not be
estimable if the variation in the number of plasmids that transfect
the virus-producer cells in the generation of pseudotyped virions,
or the segregation of envelope proteins within the transfected cells
are too large. This is due to the fact that, in this case, virions do not
express many hetero-trimers, which contain most information on
the stoichiometry of neutralization. To ascertain that the
experimental procedure is indeed a viable approach for the
estimation of the stoichiometry of entry, the variation in
transfection and segregation coefficient should be determined.
As defined in our study on HIV entry [1], the measurements for
the amount of virions that productively infect a cell is the relative
infectivity, RI. In contrast, Yang et al. [2] define the percent
neutralization sensitivity, %NS, for studying the stoichiometry of
neutralization. The relation between these variables is simply
%NS~1{RI. Yang’s model expresses the stoichiometry of entry
T and the stoichiometry of neutralization N as continuous
parameters. Since only an integer valued number of trimers can
actually bind to the CD4-receptor and 1,2 or 3 monoclonal
antibodies can bind to one trimer, N and T have to be discrete
variables, as we modeled them in all models. The most important
difference between our models and those of Yang and Klasse
[2,28] is that we include the distribution of trimer numbers. We
show, that this distribution, i.e. the frequencies of virions with
s~1,2,...trimers, is an important input factor which affects the
predictions for the relative infectivities and therefore the estimates
of the stoichiometric parameters strongly.
Figure 5. Relative infectivity curves for the best estimate of the stoichiometry of neutralization N in the different models. The
imperfect transfection model and the segregation model are omitted due to the lack of reliability of the estimates. In the other models, the best fit is
obtained for N~1. The entry parameters are included from the estimation of the entry parameters in [1]: T~8 for the basic model, T~2, a~10nm
for the proximity model and T1=2~100, h~1:26 for the soft threshold model.
doi:10.1371/journal.pcbi.1000713.g005
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two ways. Either we use stoichiometric parameters of entry that
were independently estimated to estimate the stoichiometry of
neutralization from the neutralization data. Or, we attempt to
estimate both, the stoichiometric parameters of entry and
neutralization from the neutralization data. For the basic,
proximity, and soft threshold models, we can infer the stoichiom-
etry of neutralization. The stoichiometry of neutralization cannot
be inferred from the imperfect transfection model and the
segregation model if we use previous estimates for the parameters
of these models. This is due to the lack of hetero-trimers according
to the previously estimated parameters. Pooling over all antibod-
ies, the fit to the data for all these models suggest that, on average,
one antibody is sufficient for trimer neutralization. We also obtain
a stoichiometry of neutralization of one if we stratify the data by
antibody binding sites. Using the second approach in which we try
to estimate the stoichiometric parameters of neutralization and
entry simultaneously from the neutralization data, we find that the
estimates of the stoichiometry of neutralization largely agree with
those obtained with the first approach. However, the estimates for
the entry parameters deviate from the parameters obtained by
analyzing entry data only [1]. This is due to the extremely small
differences between the predictions of the relative infectivities for
some parameter combinations. Hence, we suggest to determine
the entry parameters independently from experiments similar to
those presented in [2].
As we suggested previously [1], a reliable estimate of the
stoichiometric parameters of entry requires elucidating certain
aspects of the experimental assays further. We suggest the
following line of experiments (in the order of importance):
1. Determination of the variation between the fractions of
mutated envelope proteins of the Env pool and mutated Env
encoding plasmids and the degree of segregation. This point is
even more important than the determination of the distribution
of trimer numbers because the viability of experimental
approach for the estimation of the stoichiometry of neutrali-
zation hinges upon low variation and segregation coefficients.
2. Determination of the trimer number distribution g. This could
be done by cryoelectron tomography as in [16], [18]. As for the
estimation of the stoichiometry of entry, the trimer number
distribution is a very important input parameter, because it
enters in all models.
3. In a last line of experiments one has to check if trimers can
move freely on the virion’s surface, because recent cryoelectron
micoscropy tomograhical studies conclude either fixed posi-
tions of trimers on the surface [18] or free movement of trimers
[16,17]. If trimers can change their positions, the proximity
model would not be valid.
These experiments allow a deeper insight into the biological
processes during transfection and infection of target cells. Some
models could be falsified or combined to one model, which
explains the infectivity assays best. The entry parameters for this
final model should be studied first and then, the stoichiometry of
trimer neutralization can be studied.
In the current analysis, experimental data from 4 different virus
strains neutralized by monoclonal antibodies with different
specificities and mode of action are included. Due to the relatively
low number of data points available, stoichiometries of individual
antibodies could not be assessed. While the majority of interactions
appear to follow a N~1 stoichiometry, we can currently not rule
out that stoichiometric differences between monoclonal antibodies
exist.
The stoichiometry of trimer neutralization, which is the focus of
this paper, should not be confused with the single- and multi-hit
model parameters proposed by McLain and Dimmock [29]. Their
models aimed to determine the number of antibodies required for
the neutralization of an entire virion. Since it has been established
that virions differ in the number of trimers on their surface [18,30]
we cannot expect to describe virion neutralization with a single
parameter. More recently, stoichiometric parameters have been
proposed for the quantitative description of HIV entry and
neutralization [2,11,14,31]. In particular, HIV neutralization is
currently described by the number of trimers on the virion’s
surface, the stoichiometry of entry and trimer neutralization. In
combination with the stoichiometry of entry, the stoichiometry of
trimer neutralization can be used to estimate the mean number of
antibodies that neutralize a single virion. The number of trimers
per virion varies and so does the number of trimers, which have to
be neutralized. As an example, let us assume that the basic model
is valid and that the stoichiometry of entry is 8, i.e. 8 functional
trimers are needed to infect a target cell. Imagine a virion with 10
trimers. If two of them are neutralized, this virion is still infectious.
Neutralizing one more trimer renders the virion non-infectious. In
total, at least 3 trimers have to be neutralized for neutralizing the
virion. Assuming that one antibody is able to neutralize one
trimer, i.e. N~1, at least 3 antibodies are needed to neutralize the
virion with 10 trimers. However, 3 antibodies may not be
sufficient. Imagine, for example, that the 3 antibodies bind to the 3
envelope proteins of the same trimer, then only one trimer is
neutralized. While we need at least 3 antibodies to neutralize this
virion, 7 antibodies will be sufficient. Still assuming T~8 and
N~1, a virion with 30 trimers would be neutralized if at least 23
trimers loose their functionality. Therefore at least 23 but not
more than 67 antibodies are needed. We can estimate the mean
number of monoclonal antibodies required to neutralize virions
with 10 trimers as 3:23+0:48 and virions with 30 trimers as
33:65+3:74 (these estimates are based on simulations with 105
virtual virions). We plan to study how the stoichiometries of entry
and neutralization relate to the neutralization of a population of
viruses in the future.
The models we present here address the question of how many
monoclonal antibodies are needed to neutralize a single trimer in
vitro. In vivo however, there will always be a mixture of different
monoclonal antibodies attacking the virions. To predict the effect
of a polyclonal antibody response on virus replication, it will be
necessary, in addition to estimating the stoichiometries for each
antibody clone, to investigate how they synergize or antagonize
each other. To illustrate what exactly we mean by synergy and
antagonism assume, for example, we have two antibody clones, A
and B with stoichiometries of neutralization of N~2, and N~3,
respectively. If one antibody A is bound to a trimer already, how
many antibodies B are then required for neutralization? Further,
does it matter where the B antibodies bind, i.e. whether they bind
to the same envelope protein as antibody A or to a different one?
To assess if the antibodies synergize or antagonize in this sense,
one can perform experiments using pseudotyped viruses with
mixed envelope proteins (very similar to those that have been
conducted to estimate the stoichiometry of neutralization) in
combination with our mathematical models. For this particular
question, one should mix envelope proteins resistant to neutral-
ization by antibody A with envelope proteins resistant to
neutralization by antibody B. The relative infectivity of these
pseudotyped viruses has to be measured under saturation of
antibody A and B. If antibody A and B synergize, the relative
infectivity in this experiment will be lower than if the antibodies
act independently. This is because the only trimer that is not
Stoichiometry of HIV Neutralization
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resistance and one with B-resistance. If antibodies A and B act
independently these trimers are not neutralized because they bind
fewer than necessary numbers of A and B. How the understanding
of the stoichiometry of neutralization by a mixture of antibodies
scales up to the level of the entire virion depends strongly on
whether the antibody binding sites overlap. If they do, the number
of antibodies required for neutralization will be lower than in the
case of non-overlapping antibody binding sites because there is less
opportunity for antibodies to bind uselessly.
We presented a modeling framework which enables us to
investigate the number of antibodies that are needed to neutralize
a single trimer and if this quantity varies between different
antibodies. As the stoichiometry of trimer neutralization is the
basis for the calculation of the stoichiometry of virion and
population neutralization, it is an important parameter for the
quantitative understanding of the protection antibodies may
confer.
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